ZYUS — Zyus Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Zyus Life Sciences, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	9.15	8.45	8.59	0.212	5.85
Net Total Accounts Receivable
Net Total Receivables	0.069	0.059	0.044	0.243	0.627
Total Inventory
Prepaid Expenses
Total Current Assets	9.22	8.51	8.64	6.27	9.39
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0	0	0	17	13.9
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	9.22	8.51	8.64	64.7	41.6
Payable / Accrued
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Current Liabilities	0.3	0.319	0.096	14.3	13.2
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	0.3	0.319	0.096	60	18.5
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	8.92	8.19	8.54	4.74	23.1
Total Liabilities & Shareholders' Equity	9.22	8.51	8.64	64.7	41.6
Total Common Shares Outstanding